Keratinocyte cancer

5.4 Pathology of rare tumours

From Cancer Guidelines Wiki

Background[edit source]

Rare keratinocytic tumours include Merkel cell carcinoma (MCC), cutaneous Paget’s disease and atypical fibroxanthoma.

Pathology of Merkel cell carcinoma[edit source]

Merkel cell carcinoma is a high-grade primary neuroendocrine carcinoma of the skin. It primarily effects the elderly and the immunosuppressed. Both chronic ultraviolet (UV) light exposure and integration of the Merkel cell polyomavirus are associated with MCC.[1]

Histologically MCC is composed of small blue round cells with stippled chromatin and an inconspicuous nucleolus. It stains positively for Cytokeratin 20 (CK20) and for the neuroendocrine markers chromogranin A and synaptophysin.

Merkel cell carcinoma is locally aggressive and also shows a tendency to metastasise to local lymph nodes. It can also be more widely metastatic.[1]

Sentinel lymph node biopsy is often indicated and specialist referral is recommended when this diagnosis is made.

Merkel cell carcinoma is staged according to the American Joint Committee on Cancer (AJCC) staging manual.[2]

Back to top

Pathology of mammary and extramammary Paget’s disease[edit source]

Mammary Paget’s disease (also called Paget’s disease of the nipple) is a condition that involves the nipple and areolar complex. It has an eczematous appearance. Paget’s disease is often associated with underlying carcinoma of the breast.[1]

Histologically there is intraepidermal spread of carcinoma cells in a single cell scattering pattern (so called Pagetoid spread).

Extramammary Paget’s disease is most common in the anogenital region. It may be primary to the skin or may present as complicated colorectal carcinoma, urethral carcinoma or carcinoma of the female genital tract.[1]

Specialist referral is recommended when this diagnosis is made.

Back to top

Pathology of atypical fibroxanthoma[edit source]

Atypical fibroxanthoma is a dermally based tumour of uncertain histogenesis which is characterised by its pleomorphic appearance but generally low-grade clinical behaviour.[1] It occurs in the older age group, usually in the setting of marked solar elastosis on the head and neck. Atypical fibroxanthoma presents as a solitary nodule, which is often ulcerated and has a short clinical time course.

Histologically, the tumour is often pleomorphic and shows frequent and abnormal mitotic figures. There is a spindle cell variant.[1]

Immunoperoxidase stains are very important in the diagnosis of atypical fibroxanthoma, which is essentially a diagnosis of exclusion. The differential diagnosis includes squamous cell carcinoma, melanoma, leiomyosarcoma and angiosarcoma. Atypical fibroxanthoma usually stains for CD10 and is negative for the markers of cutaneous squamous cell carcinoma, melanoma, angiosarcoma and leiomyosarcoma. Frequently only CD10 is positive. Most atypical fibroxanthomas are benign, provided that strict criteria are used for diagnosis. A low percentage of cases recur and metastasis are rarely reported. If the tumour involves the subcutis it is better classified as a 'pleomorphic dermal sarcoma not otherwise specified' (PDS-NOS). Pleomorphic dermal sarcoma is a deeper form of AFX. It infiltrates into the subcutis and shows greater risk of recurrence and metastasis (although metastasis is rare).

Practice Point[edit source]

Practice pointQuestion mark transparent.png

PP 5.4.1 When a diagnosis is made on histopathology in the following conditions referral to a specialist for assessment and treatment should be undertaken:

  • Merkel cell carcinoma
  • extramammary Paget’s disease
  • mammary Paget’s disease (refer to a breast surgeon)
  • atypical fibroxanthoma or pleomorphic dermal sarcoma not otherwise (consider referral).

References[edit source]

  1. 1.0 1.1 1.2 1.3 1.4 1.5 Elder DE, Massi D, Scolyer RA, Willemze R. WHO Classification of Skin Tumours. 4th edn. Lyon, France: International Agency for Research on Cancer; 2018.
  2. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, et al. (Eds.). AJCC Cancer Staging Manual (8th edition). Springer International Publishing: American Joint Commission on Cancer; 2017 [cited 2016 Dec 28].

Back to top